Clinical Trial Update: Digitalis Investigation Group (DIG) [Phase 3]

View source ↗

Summary

Phase 3 DIG trial evaluating digoxin for arrhythmias and heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Heart Failure

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED